Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study

• Status: Not yet recruiting
• Trial end date: 2027-03-31
• Target enrollment: 0
• Participant gender: Female

Summary

The objective of this study is to assess the efficacy of an implantable etonogestrel device in reducing hysterectomy rate in patients with a failed endometrial ablation.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Saskatchewan Health Authority - Regina Area
• Collaborator: University of Saskatchewan
• Treatments: Desogestrel; Etonogestrel

Criteria

Inclusion Criteria:

• Previous endometrial ablation

• Pelvic pain and/or vaginal bleeding seeking treatment

Exclusion Criteria:

• Previous or current VTE

• Liver tumour, benign or malignant, or active liver disease

• Undiagnosed abnormal genital bleeding

• Known or suspected breast cancer

• Uncontrolled hypertension

• Allergy to component of etonogestrel implant

• Lack of patient consent